Glu-P-1 (2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole).
出版信息
IARC Monogr Eval Carcinog Risk Chem Hum. 1986;40:223-33.
PMID:3473003
Abstract
摘要
相似文献
1
Glu-P-1 (2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole).Glu-P-1（2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑）。
IARC Monogr Eval Carcinog Risk Chem Hum. 1986;40:223-33.
2
Glu-P-2 (2-aminodipyrido[1,2-a:3',2'-d]imidazole).Glu-P-2（2-氨基二吡啶并[1,2-a:3',2'-d]咪唑）
IARC Monogr Eval Carcinog Risk Chem Hum. 1986;40:235-43.
3
[DNA modification and carcinogenesis--early events caused by a heterocyclic aromatic amine, Glu-P-1].[DNA修饰与致癌作用——杂环芳香胺Glu-P-1引发的早期事件]
Gan To Kagaku Ryoho. 1989 Mar;16(3 Pt 2):445-50.
4
N-acetyl derivative as the major active metabolite of 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole in rat bile.N-乙酰衍生物作为2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑在大鼠胆汁中的主要活性代谢物。
Mutat Res. 1986 Sep;175(1):23-8. doi: 10.1016/0165-7992(86)90140-5.
5
Copper, zinc-superoxide dismutase enhances the mutagenicity in Salmonella typhimurium induced by 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole.铜锌超氧化物歧化酶增强了2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑在鼠伤寒沙门氏菌中诱导的致突变性。
Mutat Res. 2008 May 31;653(1-2):14-22. doi: 10.1016/j.mrgentox.2008.02.004. Epub 2008 Feb 14.
6
11-Aminoundecanoic acid.11-氨基十一酸
IARC Monogr Eval Carcinog Risk Chem Hum. 1986;39:239-45.
7
Accumulation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-aminodipyrido[1,2-a:3',2'-d]imidazole, carcinogenic glutamic acid pyrolysis products, in plasma of patients with uremia.尿毒症患者血浆中2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑和2-氨基二吡啶并[1,2-a:3',2'-d]咪唑（致癌性谷氨酸热解产物）的蓄积。
Cancer Res. 1987 Nov 15;47(22):6150-5.
8
A-alpha-C (2-amino-9H-pyrido[2,3-b]indole).
IARC Monogr Eval Carcinog Risk Chem Hum. 1986;40:245-52.
9
Tumor induction in mice administered neonatally with 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole or 2-amino-dipyrido[1,2-a:3',2'-d]imidazole.新生期给予2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑或2-氨基二吡啶并[1,2-a:3',2'-d]咪唑的小鼠的肿瘤诱导。
Cancer Lett. 1988 Jul;41(1):75-80. doi: 10.1016/0304-3835(88)90057-2.
引用本文的文献
1
Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion.短期给予2-氨基-3-甲基咪唑并[4,5-f]喹啉联合部分肝切除，随后用苯巴比妥或低剂量3'-甲基-4-二甲基氨基偶氮苯促进，可呈剂量依赖性诱导肝脏和甲状腺肿瘤性病变。
Jpn J Cancer Res. 1988 Jun;79(6):691-7. doi: 10.1111/j.1349-7006.1988.tb02224.x.
Zotero 插件